The Department of Infectious Diseases at the German Medical Institute (GMI) is the first independent department of its kind in Cyprus. We provide high quality services related to the prevention, diagnosis, and treatment of infectious diseases both to oncological or other immunocompromised patients and to the general population.
We collaborate with the Departments of Microbiology and Radiology, as well as with the Department of Nuclear Medicine. They are all equipped with state-of-the-art technology, contributing to the diagnosis and follow-up of infections.
Our department is actively involved in developing guidelines for the optimal treatment of infections, as well as preparing research studies in collaboration with European and international networks of infectious disease departments and clinics.
We regularly conduct research in the field of Infectious Diseases in Cyprus, Greece and abroad, to provide our patients with the most innovative options for the diagnosis and treatment of difficult or rare infectious diseases.
Infectious Diseases Department
Infectious Diseases Department
Infectious Diseases Department
We need your consent before you can continue on our website.
If you are under 16 and wish to give consent to optional services, you must ask your legal guardians for permission.
We use cookies and other technologies on our website. Some of them are essential, while others help us to improve this website and your experience.
Personal data may be processed (e.g. IP addresses), for example for personalized ads and content or ad and content measurement.
You can find more information about the use of your data in our privacy policy.
There is no obligation to consent to the processing of your data in order to use this offer.
You can revoke or adjust your selection at any time under Settings.
Please note that based on individual settings not all functions of the site may be available.
Some services process personal data in the USA. With your consent to use these services, you also consent to the processing of your data in the USA pursuant to Art. 49 (1) lit. a GDPR. The ECJ classifies the USA as a country with insufficient data protection according to EU standards. For example, there is a risk that U.S. authorities will process personal data in surveillance programs without any existing possibility of legal action for Europeans.